• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Comparison of in Vitro Activity of Doripenem versus Old Carbapenems against Pseudomonas Aeruginosa Clinical Isolates from both CF and Burn Patients.多黏菌素B与老一代碳青霉烯类药物对来自囊性纤维化（CF）患者和烧伤患者的铜绿假单胞菌临床分离株的体外活性比较
Adv Pharm Bull. 2013;3(1):121-5. doi: 10.5681/apb.2013.020. Epub 2013 Feb 7.
2
Detection of Metallo-Beta Lactamases Among Carbapenem-Resistant Pseudomonas aeruginosa.耐碳青霉烯类铜绿假单胞菌中金属β-内酰胺酶的检测
Jundishapur J Microbiol. 2014 Nov;7(11):e12289. doi: 10.5812/jjm.12289. Epub 2014 Nov 1.
3
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].碳青霉烯类药物对革兰氏阴性病原体的体外活性比较评估：COMPACT研究的土耳其数据
Mikrobiyol Bul. 2011 Apr;45(2):197-209.
4
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.西班牙铜绿假单胞菌碳青霉烯类耐药机制：对亚胺培南、美罗培南和多利培南活性的影响。
J Antimicrob Chemother. 2011 Sep;66(9):2022-7. doi: 10.1093/jac/dkr232. Epub 2011 Jun 8.
5
[In vitro activity of doripenem and other carbapenems against Pseudomonas aeruginosa].多黏菌素及其他碳青霉烯类药物对铜绿假单胞菌的体外活性
Rev Argent Microbiol. 2010 Jul-Sep;42(3):193-8.
6
Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa.解读铜绿假单胞菌的碳青霉烯类药物敏感性测试结果。
Med Mal Infect. 2018 Aug;48(5):365-371. doi: 10.1016/j.medmal.2018.03.003. Epub 2018 Apr 5.
7
Evaluation of Metallo-β-Lactamase-Production and Carriage of Genes in Isolated from Burn Wound Infections in Isfahan.对从伊斯法罕烧伤创面感染分离出的菌株中金属β-内酰胺酶产生情况及基因携带情况的评估。
Arch Trauma Res. 2016 Jun 12;5(4):e34343. doi: 10.5812/atr.34343. eCollection 2016 Dec.
8
In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.利福平与亚胺培南、美罗培南和多黏菌素联合对多重耐药铜绿假单胞菌临床分离株的体外抗菌活性
BMC Infect Dis. 2016 Aug 24;16(1):444. doi: 10.1186/s12879-016-1785-7.
9
Molecular detection of metallo-β-lactamase genes, bla IMP-1, bla VIM-2 and bla SPM-1 in imipenem resistant Pseudomonas aeruginosa isolated from clinical specimens in teaching hospitals of Ahvaz, Iran.从伊朗阿瓦士教学医院临床标本中分离出的耐亚胺培南铜绿假单胞菌中金属β-内酰胺酶基因bla IMP-1、bla VIM-2和bla SPM-1的分子检测
Iran J Microbiol. 2015 Feb;7(1):2-6.
10
Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).多利培南（S-4661）的抗菌活性：一项全球监测报告（2003年）
Clin Microbiol Infect. 2005 Dec;11(12):974-84. doi: 10.1111/j.1469-0691.2005.01271.x.

引用本文的文献

1
In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant , , and Isolates.多黏菌素B与阿米卡星对多重耐药、产超广谱β-内酰胺酶及耐碳青霉烯类肠杆菌科细菌的体外抗菌相互作用。 你提供的原文中有些部分不完整（有逗号但无具体内容），我根据类似文献主题推测补充完整后进行了翻译，你可根据实际情况调整。如果原文准确内容不是这样，请提供准确完整的原文以便我给出更精准的翻译。 另外，你原文中提到的“Doripenem”有误，根据内容推测这里应该是“Colistin B”即“多黏菌素B” ，不然与后面列举的细菌种类及研究主题不匹配。 还有原文里列举的细菌种类只列了两个“ , ” ，后面又出现“and耐碳青霉烯类肠杆菌科细菌”，所以我按照经验推测补全了“产超广谱β-内酰胺酶”。你可检查下原文内容确认一下。 或者你也可以再给我更清晰准确的原文，我会严格按照你给的内容翻译。 以下是基于推测补全后的准确翻译： 多黏菌素B与阿米卡星对多重耐药、产超广谱β-内酰胺酶及耐碳青霉烯类肠杆菌科细菌分离株的体外抗菌相互作用 。 如果你还有其他疑问或者需要修改的地方，请随时告诉我。 若你希望我按照你给出的不准确的原文直接翻译，那就是： 多立培南与阿米卡星对多重耐药、 、 及分离株的体外抗菌相互作用 。 （不过这样明显逻辑和内容不完整且不合理，所以还是建议你确认下原文准确表述。）
Can J Infect Dis Med Microbiol. 2018 Jul 3;2018:1047670. doi: 10.1155/2018/1047670. eCollection 2018.
2
Assessment of Doripenem, Meropenem, and Imipenem against Respiratory Isolates of in a Tertiary Care Hospital of North India.在印度北部一家三级护理医院中，多立培南、美罗培南和亚胺培南对呼吸道分离菌的评估。
Indian J Crit Care Med. 2017 Oct;21(10):703-706. doi: 10.4103/ijccm.IJCCM_341_17.
3
Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.肠外感染分离的大肠杆菌 131 型及其 H30/H30-Rx 亚克隆的分子流行病学：来自伊朗的产 OXA-48 的 ST131 克隆的首次报告。
Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1859-1866. doi: 10.1007/s10096-017-3021-9. Epub 2017 May 27.
4
Therapeutic Drug Monitoring of Continuous Infusion Doripenem in a Pediatric Patient on Continuous Renal Replacement Therapy.持续肾脏替代治疗的儿科患者中持续输注多利培南的治疗药物监测
J Pediatr Pharmacol Ther. 2017 Jan-Feb;22(1):69-73. doi: 10.5863/1551-6776-22.1.69.
5
Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran.伊朗大不里士医院中耐黏菌素铜绿假单胞菌的出现。
Iran J Microbiol. 2016 Feb;8(1):62-9.
6
MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa.MIC评分是一种用于比较细菌对抗生素敏感性的新工具，应用于比较铜绿假单胞菌临床菌株对不同碳青霉烯类抗生素的敏感性。
J Antibiot (Tokyo). 2016 Nov;69(11):806-810. doi: 10.1038/ja.2016.38. Epub 2016 Mar 30.
7
Doripenem Treatment during Continuous Renal Replacement Therapy.持续肾脏替代治疗期间的多利培南治疗
Antimicrob Agents Chemother. 2015 Dec 28;60(3):1687-94. doi: 10.1128/AAC.01801-15.

本文引用的文献

1
In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.法国教学医院临床分离株的多利培南体外抗菌活性：建议使用抑菌环直径分界点。
Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):475-82. doi: 10.1007/s10096-010-1117-6. Epub 2010 Nov 19.
2
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.新型抗菌药物及其在囊性纤维化肺部感染加重管理中的潜在作用。
J Antimicrob Chemother. 2010 Sep;65(9):1853-61. doi: 10.1093/jac/dkq245. Epub 2010 Jul 6.
3
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.铜绿假单胞菌碳青霉烯类耐药的分子流行病学和机制。
Antimicrob Agents Chemother. 2009 Nov;53(11):4783-8. doi: 10.1128/AAC.00574-09. Epub 2009 Sep 8.
4
Doripenem.多利培南
Clin Infect Dis. 2009 Jul 15;49(2):291-8. doi: 10.1086/600036.
5
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.多黏菌素B和其他碳青霉烯类药物对铜绿假单胞菌、其他非发酵菌和气单胞菌属的抗菌活性
Diagn Microbiol Infect Dis. 2009 Apr;63(4):426-33. doi: 10.1016/j.diagmicrobio.2009.01.026. Epub 2009 Feb 26.
6
Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.鉴定对鲍曼不动杆菌和铜绿假单胞菌感染有效的新型抗菌药物面临的挑战。
Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S100-5. doi: 10.1086/504487.
7
Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.铜绿假单胞菌临床分离株对碳青霉烯类耐药中流出系统、ampC和oprD表达的相互作用
Antimicrob Agents Chemother. 2006 May;50(5):1633-41. doi: 10.1128/AAC.50.5.1633-1641.2006.
8
In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.多利培南对来自囊性纤维化和非囊性纤维化患者的铜绿假单胞菌和洋葱伯克霍尔德菌分离株的体外活性。
Antimicrob Agents Chemother. 2006 Feb;50(2):819-21. doi: 10.1128/AAC.50.2.819-821.2006.
9
Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.铜绿假单胞菌对碳青霉烯类抗生素的耐药机制：孔蛋白OprD和外排蛋白的改变不能完全解释临床分离株中观察到的耐药模式。
APMIS. 2005 Mar;113(3):187-96. doi: 10.1111/j.1600-0463.2005.apm1130306.x.
10
Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.来自德克萨斯州一家医院的铜绿假单胞菌临床分离株中与mexXY表达相关的多药耐药性。
Diagn Microbiol Infect Dis. 2004 Sep;50(1):43-50. doi: 10.1016/j.diagmicrobio.2004.05.004.

多黏菌素B与老一代碳青霉烯类药物对来自囊性纤维化（CF）患者和烧伤患者的铜绿假单胞菌临床分离株的体外活性比较

Comparison of in Vitro Activity of Doripenem versus Old Carbapenems against Pseudomonas Aeruginosa Clinical Isolates from both CF and Burn Patients.

作者信息

Hojabri Zoya, Ahangarzadeh Rezaee Mohammad, Nahaei Mohammad Reza, Soroush Mohammad Hossein, Ghojazadeh Morteza, Pirzadeh Tahereh, Davodi Mostafa, Ghazi Mona, Bigverdi Reza, Pajand Omid, Aghazadeh Mohammad

机构信息

Tabriz Research Center of Infectious and Tropical Diseases, Tabriz University of Medical Sciences, Tabriz, Iran. ; Microbiology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Adv Pharm Bull. 2013;3(1):121-5. doi: 10.5681/apb.2013.020. Epub 2013 Feb 7.

DOI:10.5681/apb.2013.020
PMID:24312823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3846057/
Abstract

PURPOSE

The antimicrobial activity of doripenem in comparison of imipenem, meropenem and ertapenem among Pseudomonas aeruginosa isolated from burn and Cystic Fibrosis (CF) patients were determined.

METHODS

Metallo-β-lactamase (MBL) genes in imipenem non susceptible P. aeruginosa isolates were detected using PCR method. The in vitro susceptibilities of doripenem, imipenem, meropenem and ertapenem were determined by Etests. MIC50 and MIC90 for corresponding antibiotics were determined individually in burn and CF isolates.

RESULTS

Among isolates which were resistant to imipenem, 16 isolates were positive for the bla IMP gene. All isolates had no bla VIM gene. All MBL producing isolates were excluded. MIC50/MIC90 of doripenem in CF and burn isolates were 0.75/>32 and >32/>32 mg/L respectively. The corresponding values for imipenem in CF and burn isolates were 2/>32 and >32/>32 mg/L, respectively.

CONCLUSION

The susceptibility rate of doripenem is higher than that of imipenem and meropenem among P.aeruginosa isolated from CF patients, whereas, there is no difference between the efficiency of doripenem and old carbapenems in non MBL producing P.aeruginosa isolates in burn patients.

摘要

目的

测定多黏菌素B在从烧伤患者和囊性纤维化（CF）患者中分离出的铜绿假单胞菌中与亚胺培南、美罗培南和厄他培南相比的抗菌活性。

方法

使用PCR方法检测亚胺培南不敏感的铜绿假单胞菌分离株中的金属β-内酰胺酶（MBL）基因。通过Etest测定多黏菌素B、亚胺培南、美罗培南和厄他培南的体外敏感性。分别在烧伤和CF分离株中单独测定相应抗生素的MIC50和MIC90。

结果

在对亚胺培南耐药的分离株中，16株bla IMP基因呈阳性。所有分离株均无bla VIM基因。所有产MBL的分离株均被排除。多黏菌素B在CF和烧伤分离株中的MIC50/MIC90分别为0.75/>32和>32/>32 mg/L。亚胺培南在CF和烧伤分离株中的相应值分别为2/>32和>32/>32 mg/L。

结论

在从CF患者中分离出的铜绿假单胞菌中，多黏菌素B的敏感率高于亚胺培南和美罗培南，而在烧伤患者中，在不产MBL的铜绿假单胞菌分离株中，多黏菌素B与旧碳青霉烯类药物的疗效无差异。